The FDA warns of continuing reports of adverse events associated with use of EzriCare Artificial Tears and Delsam Pharma’s Artificial Eye Ointment, which were previously recalled due to potential bacterial contamination.
Recommendations for Healthcare Providers
-
Immediately discontinue using EzriCare Artificial Tears and Delsam Pharma’s Artificial Eye Ointment.
-
Advise patients who used either product to monitor for signs and symptoms of infection. Perform culture and antimicrobial susceptibility testing when clinically indicated.
-
Testing of patients who have used either product and are not experiencing any signs or symptoms of infection is NOT recommended.
- Report adverse events to FDA’s MedWatch Adverse Event Reporting program.
None of the MHC pharmacies have EzriCare Artificial Tears or Delsam Pharma’s Artificial Eye Ointment in their formulary.